本文章的引用
本文章的通讯作者
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
- 本文章浏览次数 (5010)
All Articles published online
|
2011-07-08 (publication date) through 2025-04-15
本文章的被引频次
本文章的期刊信息
出版物名称
世界华人消化杂志
ISSN
1009-3079
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | 王令仪, 王硕, 王源, 阮克锋, 冯怡. 麦冬多糖MDG-1对糖尿病小鼠糖耐量及肠道菌群的影响. 世界华人消化杂志 2011; 19(19): 2058-2062 [DOI: 10.11569/wcjd.v19.i19.2058] |
|---|---|
| URL: | https://www.wjgnet.com/1009-3079/full/v19/i19/2058.htm |
| 编号 | Citing Articles |
| 1 |
Kaiqi Li, Shiqi Wang, Wuyi Qu, Abdelkareem A. Ahmed, Wael Enneb, Mohammad Diya’ Obeidat, Hao-Yu Liu, Tadelle Dessie, In Ho Kim, Saber Y. Adam, Demin Cai. Natural products for Gut-X axis: pharmacology, toxicology and microbiology in mycotoxin-caused diseases. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1419844
|
| 2 |
Hongkun Xue, Beimeng Liang, Yu Wang, Haiyan Gao, Saisai Fang, Kaifang Xie, Jiaqi Tan. The regulatory effect of polysaccharides on the gut microbiota and their effect on human health: A review. International Journal of Biological Macromolecules 2024; 270: 132170 doi: 10.1016/j.ijbiomac.2024.132170
|
| 3 |
Feng Chen, Qi Wen, Jun Jiang, Hai-Long Li, Yin-Feng Tan, Yong-Hui Li, Nian-Kai Zeng. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?. Journal of Ethnopharmacology 2016; 179: 253 doi: 10.1016/j.jep.2015.12.031
|
| 4 |
Yunyun Zhu, Wenjuan Cong, Lan Shen, Hai Wei, Yuan Wang, Lingyi Wang, Kefeng Ruan, Fei Wu, Yi Feng. Fecal metabonomic study of a polysaccharide, MDG-1 from Ophiopogon japonicus on diabetic mice based on gas chromatography/time-of-flight mass spectrometry (GC TOF/MS). Mol. BioSyst. 2014; 10(2): 304 doi: 10.1039/C3MB70392D
|
| 5 |
Xianpeng Zu, Dale G. Nagle, YuDong Zhou, Weidong Zhang. Systems Biology and its Application in TCM Formulas Research. 2018; : 97 doi: 10.1016/B978-0-12-812744-5.00005-9
|
| 6 |
Chuyue Pan, Qinglong Guo, Na Lu. Role of Gut Microbiota in the Pharmacological Effects of Natural Products. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/2682748
|
| 7 |
Xiaoyan Xia, Jiao Xiao. Natural Ingredients from Medicine Food Homology as Chemopreventive Reagents against Type 2 Diabetes Mellitus by Modulating Gut Microbiota Homoeostasis. Molecules 2021; 26(22): 6934 doi: 10.3390/molecules26226934
|
| 8 |
Lin-lin Shi, Yuan Li, Yuan Wang, Yi Feng. MDG-1, an Ophiopogon polysaccharide, regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice. International Journal of Biological Macromolecules 2015; 81: 576 doi: 10.1016/j.ijbiomac.2015.08.057
|
| 9 |
Yang PING, Jianing LIU, Huilin WANG, Yan WANG, Hongbin QIU, Yu ZHANG. Research progress in the treatment of an immune system disease—type 1 diabetes—by regulating the intestinal flora with Chinese medicine and food homologous drugs. Bioscience of Microbiota, Food and Health 2024; 43(3): 150 doi: 10.12938/bmfh.2023-068
|
| 10 |
Thao T. B. Cao, Kun-Chang Wu, Jye-Lin Hsu, Chih-Shiang Chang, Chiahung Chou, Chen-Yuan Lin, Yu-Min Liao, Pei-Chun Lin, Liang-Yo Yang, Hsiang-Wen Lin. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.573891
|
| 11 |
Ling-Yi Wang, Yuan Wang, De-Sheng Xu, Ke-Feng Ruan, Yi Feng, Shuo Wang. MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model. Journal of Ethnopharmacology 2012; 143(1): 347 doi: 10.1016/j.jep.2012.06.050
|